BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12816717)

  • 1. [Evaluation on the disability weight of Alzheimer's disease and Parkinson's disease in Beijing].
    Duan LL; Zhang ZX; Huang JB; Hong X; Wen HB; Wang QH; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):220-3. PubMed ID: 12816717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
    Sabbagh MN; Silverberg N; Bircea S; Majeed B; Samant S; Caviness JN; Reisberg B; Adler CH
    Parkinsonism Relat Disord; 2005 Aug; 11(5):311-5. PubMed ID: 15886042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of disease related to Parkinson's disease in Spain in the year 2000.
    Cubo E; Alvarez E; Morant C; de Pedro Cuesta J; Martínez Martín P; Génova R; Freire JM
    Mov Disord; 2005 Nov; 20(11):1481-7. PubMed ID: 16037922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
    Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
    Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
    Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
    Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
    Jellinger KA; Attems J
    Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
    Zhang ZX; Anderson DW; Huang JB; Li H; Hong X; Wei J; Yang EL; Maraganore DM
    Mov Disord; 2003 Jul; 18(7):764-72. PubMed ID: 12815655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rates of progression in Alzheimer's disease and Parkinson's disease.
    Rosen TJ; Growdon JH; Corkin S
    J Neural Transm Suppl; 1987; 24():105-7. PubMed ID: 3479521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional disability in early Alzheimer's disease - a validation study of the Italian version of the disability assessment for dementia scale.
    De Vreese LP; Caffarra P; Savarè R; Cerutti R; Franceschi M; Grossi E;
    Dement Geriatr Cogn Disord; 2008; 25(2):186-94. PubMed ID: 18196940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease and functional decline in older Mexican Americans.
    Schneider MG; Shardell M
    Parkinsonism Relat Disord; 2008; 14(5):397-406. PubMed ID: 18343181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
    Sitburana O; Rountree S; Ondo WG
    J Neurol Sci; 2008 Sep; 272(1-2):77-82. PubMed ID: 18556024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.